132 related articles for article (PubMed ID: 8841408)
1. Different susceptibilities of fibulin-1 and fibulin-2 to cleavage by matrix metalloproteinases and other tissue proteases.
Sasaki T; Mann K; Murphy G; Chu ML; Timpl R
Eur J Biochem; 1996 Sep; 240(2):427-34. PubMed ID: 8841408
[TBL] [Abstract][Full Text] [Related]
2. Sites of nidogen cleavage by proteases involved in tissue homeostasis and remodelling.
Mayer U; Mann K; Timpl R; Murphy G
Eur J Biochem; 1993 Nov; 217(3):877-84. PubMed ID: 8223643
[TBL] [Abstract][Full Text] [Related]
3. Fibulin-2 binds to the short arms of laminin-5 and laminin-1 via conserved amino acid sequences.
Utani A; Nomizu M; Yamada Y
J Biol Chem; 1997 Jan; 272(5):2814-20. PubMed ID: 9006922
[TBL] [Abstract][Full Text] [Related]
4. Structure and expression of fibulin-2, a novel extracellular matrix protein with multiple EGF-like repeats and consensus motifs for calcium binding.
Pan TC; Sasaki T; Zhang RZ; Fässler R; Timpl R; Chu ML
J Cell Biol; 1993 Dec; 123(5):1269-77. PubMed ID: 8245130
[TBL] [Abstract][Full Text] [Related]
5. Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens.
Sasaki T; Göhring W; Mann K; Maurer P; Hohenester E; Knäuper V; Murphy G; Timpl R
J Biol Chem; 1997 Apr; 272(14):9237-43. PubMed ID: 9083057
[TBL] [Abstract][Full Text] [Related]
6. Sequence, recombinant expression and tissue localization of two novel extracellular matrix proteins, fibulin-3 and fibulin-4.
Giltay R; Timpl R; Kostka G
Matrix Biol; 1999 Oct; 18(5):469-80. PubMed ID: 10601734
[TBL] [Abstract][Full Text] [Related]
7. Fibrillin degradation by matrix metalloproteinases: identification of amino- and carboxy-terminal cleavage sites.
Hindson VJ; Ashworth JL; Rock MJ; Cunliffe S; Shuttleworth CA; Kielty CM
FEBS Lett; 1999 Jun; 452(3):195-8. PubMed ID: 10386589
[TBL] [Abstract][Full Text] [Related]
8. Dimer model for the microfibrillar protein fibulin-2 and identification of the connecting disulfide bridge.
Sasaki T; Mann K; Wiedemann H; Göhring W; Lustig A; Engel J; Chu ML; Timpl R
EMBO J; 1997 Jun; 16(11):3035-43. PubMed ID: 9214621
[TBL] [Abstract][Full Text] [Related]
9. Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum.
Lark MW; Williams H; Hoernner LA; Weidner J; Ayala JM; Harper CF; Christen A; Olszewski J; Konteatis Z; Webber R
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):245-52. PubMed ID: 7717983
[TBL] [Abstract][Full Text] [Related]
10. Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure.
Argraves WS; Tran H; Burgess WH; Dickerson K
J Cell Biol; 1990 Dec; 111(6 Pt 2):3155-64. PubMed ID: 2269669
[TBL] [Abstract][Full Text] [Related]
11. Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments.
Bini A; Wu D; Schnuer J; Kudryk BJ
Biochemistry; 1999 Oct; 38(42):13928-36. PubMed ID: 10529239
[TBL] [Abstract][Full Text] [Related]
12. Degradation of entactin by matrix metalloproteinases. Susceptibility to matrilysin and identification of cleavage sites.
Sires UI; Griffin GL; Broekelmann TJ; Mecham RP; Murphy G; Chung AE; Welgus HG; Senior RM
J Biol Chem; 1993 Jan; 268(3):2069-74. PubMed ID: 8380588
[TBL] [Abstract][Full Text] [Related]
13. Binding of mouse and human fibulin-2 to extracellular matrix ligands.
Sasaki T; Göhring W; Pan TC; Chu ML; Timpl R
J Mol Biol; 1995 Dec; 254(5):892-9. PubMed ID: 7500359
[TBL] [Abstract][Full Text] [Related]
14. Sequence of extracellular mouse protein BM-90/fibulin and its calcium-dependent binding to other basement-membrane ligands.
Pan TC; Kluge M; Zhang RZ; Mayer U; Timpl R; Chu ML
Eur J Biochem; 1993 Aug; 215(3):733-40. PubMed ID: 8354280
[TBL] [Abstract][Full Text] [Related]
15. Fibulin-1 binds the amino-terminal head of beta-amyloid precursor protein and modulates its physiological function.
Ohsawa I; Takamura C; Kohsaka S
J Neurochem; 2001 Mar; 76(5):1411-20. PubMed ID: 11238726
[TBL] [Abstract][Full Text] [Related]
16. Expression of fibulin-2 by fibroblasts and deposition with fibronectin into a fibrillar matrix.
Sasaki T; Wiedemann H; Matzner M; Chu ML; Timpl R
J Cell Sci; 1996 Dec; 109 ( Pt 12)():2895-904. PubMed ID: 9013337
[TBL] [Abstract][Full Text] [Related]
17. Fibulin-3, -4, and -5 are highly susceptible to proteolysis, interact with cells and heparin, and form multimers.
Djokic J; Fagotto-Kaufmann C; Bartels R; Nelea V; Reinhardt DP
J Biol Chem; 2013 Aug; 288(31):22821-35. PubMed ID: 23782690
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.
Okada Y; Morodomi T; Enghild JJ; Suzuki K; Yasui A; Nakanishi I; Salvesen G; Nagase H
Eur J Biochem; 1990 Dec; 194(3):721-30. PubMed ID: 2269296
[TBL] [Abstract][Full Text] [Related]
19. The 28-kDa N-terminal domain of mouse stromelysin-3 has the general properties of a weak metalloproteinase.
Murphy G; Segain JP; O'Shea M; Cockett M; Ioannou C; Lefebvre O; Chambon P; Basset P
J Biol Chem; 1993 Jul; 268(21):15435-41. PubMed ID: 8340372
[TBL] [Abstract][Full Text] [Related]
20. Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin.
Hopf M; Göhring W; Kohfeldt E; Yamada Y; Timpl R
Eur J Biochem; 1999 Feb; 259(3):917-25. PubMed ID: 10092882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
